NEW! Investment Companies Centre
Ocean Finance Loans:
£5,096m
14.50p ()
910.00p
Date: Wednesday 13 Aug 2008
LONDON (ShareCast) - Drug giant Shire has bought 81% of German biotech Jerini AG since 3 July when it announced its intention to make the voluntary €6.25 a share cash takeover.
The shares were purchased through its wholly owned indirect subsidiary Shire Deutschland Investments GmbH.
It has also published an offer document in respect of the remaining outstanding shares in Jerini. The offer period will expire on 10 September.
The €328m acquisition will expand Shire’s portfolio of treatments for rare disorders. Jerini’s lead compound, FIRAZYR, is used in the treatment of acute attacks of hereditary angioedema (HAE).
| Currency | UK Pounds |
| Share Price | 910.00p ![]() |
| Change Today | +14.50p |
| 52 Week High | 1,192.00 |
| 52 Week Low | 720.00 |
| Volume | 2,350,826 |
| Shares Issued | 560.03m |
| Market Cap | £5,096m |
| Beta | 0.64 |
| RiskGrade | 270 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Price Chg 6m |
|
|---|
| P/E |
|
|---|
| PEG |
|
|---|
| Dividend Yield |
|
|---|
| EPS Growth |
|
|---|
| Operating Margin |
|
|---|
| Strong Buy | 13 |
| Buy | 7 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 26 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 10-Sep-08 | 12-Mar-08 |
| Paid | 09-Oct-08 | 09-Apr-08 |
| Amount | 2.15¢ | 6.47¢ |
| Time | Volume / Share Price |
| 16:45 | 44,616 @ 910.00p |
| 16:35 | 285,049 @ 910.00p |
| 16:29 | 457 @ 910.00p |
| 16:29 | 455 @ 910.50p |
| 16:29 | 715 @ 910.50p |
| CEO | Angus Russell |
| CFO | Graham Hetherington |